Trials / Sponsors / Yogen Saunthararajah
Yogen Saunthararajah
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid T-cell Lymphoma, Aggressive B-cell Lymphoma, Non-Hodgkin's Lymphomas | EARLY_Phase 1 | 2017-04-25 |
| Completed | p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer Metastatic Pancreatic Adenocarcinoma | EARLY_Phase 1 | 2016-12-20 |
| Completed | Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease Sickle Cell Disease | Phase 1 | 2012-08-01 |